Loss of STAT1 from Mouse Mammary Epithelium Results in an Increased Neu-Induced Tumor Burden

• Published in: Neoplasia (New York, N.Y.) Vol. 12; no. 11; pp. 899 - 905
• Main Authors: Klover, Peter J., Muller, William J., Robinson, Gertraud W., Pfeiffer, Ruth M., Yamaji, Daisuke, Hennighausen, Lothar
• Format: Journal Article
• Language: English
• Published: United States Elsevier Inc 01.11.2010; Elsevier
• Subjects: Animals; Blotting, Western; Cell Nucleus - metabolism; Cells, Cultured; Embryo, Mammalian - cytology; Epithelium - metabolism; Female; Fibroblasts - metabolism; Kaplan-Meier Estimate; Male; Mammary Glands, Animal - metabolism; Mammary Neoplasms, Animal - genetics; Mammary Neoplasms, Animal - metabolism; Mammary Neoplasms, Animal - pathology; Mice; Mice, 129 Strain; Mice, Knockout; Mice, Transgenic; Receptor, ErbB-2 - genetics; Receptor, ErbB-2 - metabolism; STAT1 Transcription Factor - genetics; STAT1 Transcription Factor - metabolism; Tumor Burden; Tumor Cells, Cultured; IFN; NIC; STAT
• ISSN: 1476-5586; 1476-5586; 1522-8002
• DOI: 10.1593/neo.10716

Type I and type II classes of interferons (IFNs) signal through the JAK/STAT1 pathway and are known to be important in adaptive and innate immune responses and in protection against tumors. Although STAT1 is widely considered a tumor suppressor, it remains unclear, however, if this function occurs in tumor cells (cell autonomous) or if STAT1 acts primarily through immune cells. Here, the question of whether STAT1 has a cell autonomous role in mammary tumor formation was addressed in a mouse model of ERBB2/neu-induced breast cancer in the absence and presence of STAT1. For this purpose, mice that carry floxed Stat1 alleles, which permit cell-specific removal of STAT1, were generated. To induce tumors only in mammary cells lacking STAT1, Stat1 floxed mice were crossed with transgenic mice that express cre recombinase and the neu oncogene under the mouse mammary tumor virus LTR (Stat1fl/fl NIC). Stat1 was effectively deleted in mammary epithelium of virgin Stat1fl/fl NIC females. Time-to-tumor onset was significantly shorter in Stat1fl/fl NIC females than in WT NIC (Wilcoxon rank sum test, P = .02). The median time-to-tumor onset in the Stat1fl/fl NIC mice was 49.4 weeks, whereas it was 62.4 weeks in the WT NIC mice. These results suggest that STAT1 in mammary epithelial cells may play a role in suppressing tumorigenesis. The Stat1 floxed allele described in this study is also a unique resource to determine the cellular targets of IFNs and STAT1 action, which should aid our understanding and appreciation of these pathways.